美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

9.79

-0.2400-2.39%

成交量：93.33万

成交额：912.04万

市值：9.68亿

市盈率：-12.01

高：10.07

开：9.99

低：9.59

收：10.03

52周最高：18.90

52周最低：6.66

股本：9,884.86万

流通股本：5,527.05万

量比：0.77

换手率：1.69%

股息：- -

股息率：- -

每股收益(TTM):-0.8154

每股收益(LYR):0.0800

净资产收益率：-45.92%

总资产收益率：-19.22%

市净率：6.55

市盈率(LYR):122.38

数据加载中...

总览公司新闻资讯公告

Ars Pharmaceuticals, Inc.盘中异动临近收盘快速跳水5.03%报9.63美元

Eurneffy® 1毫克（肾上腺素鼻喷雾剂）获欧盟推荐批准，用于体重≥15公斤至＜30公斤儿童1型过敏反应（包括过敏性休克）的紧急治疗

Ars Pharmaceuticals, Inc.盘中异动股价大跌5.24%

ARS Pharmaceuticals将获400万美元监管里程碑付款，并有望获得高达8000万美元销售里程碑

Neffy®（肾上腺素鼻喷雾剂）在华获批，成为首个且唯一可用于社区治疗的过敏反应（严重过敏）急救产品

异动解读 | ARS制药季度业绩亮眼，股价盘前飙升7.34%

ARS Pharmaceuticals公布2025年第三季度财务结果及Neffy®的亮点

Ars Pharmaceuticals, Inc.盘中异动下午盘股价大涨5.05%

ARS Pharma推出GET Neffy®以改善重度过敏反应患者对Neffy（肾上腺素鼻喷雾剂）的获取

Ars Pharmaceuticals, Inc.盘中异动临近收盘快速下跌5.08%报9.16美元

Ars Pharmaceuticals, Inc.盘中异动早盘股价大跌5.01%

ARS PHARMACEUTICALS INC全球知识产权组合为Neffy提供至少到2039年的保护

ARS Pharmaceuticals就Neffy®（肾上腺素鼻喷剂）相关专利获得欧洲专利局有利决定

Ars Pharmaceuticals, Inc.盘中异动早盘股价大涨5.45%报10.25美元

ARS Pharmaceuticals获得高达2.5亿美元贷款额度，与Ra Capital Management和Omers Life Sciences合作加速Neffy®在美国的商业化

Neffy®（肾上腺素鼻喷剂）在日本获批，成为首个且唯一的无针头过敏反应（过敏性休克）紧急治疗药物

Ars Pharmaceuticals, Inc.盘中异动临近收盘急速下挫5.02%

异动解读 | ARS制药业绩报告后股价盘中大跌5.46%，尽管收入超预期但亏损仍然严重

BUZZ-ARS Pharma 第二季度收入超出预期，股价上涨

Ars Pharmaceuticals, Inc.盘中异动早盘快速下跌5.00%报16.63美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SPRY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"SPRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":9.79,"timestamp":1770670800000,"preClose":10.03,"halted":0,"volume":933297,"delay":0,"changeRate":-0.023928215353938208,"floatShares":55270496,"shares":98848611,"eps":-0.81541,"marketStatus":"盘前交易","change":-0.24,"latestTime":"02-10 07:07:20 EST","open":9.99,"high":10.07,"low":9.59,"amount":9120365.876697,"amplitude":0.047856,"askPrice":10,"askSize":1000,"bidPrice":8.97,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.81541,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"listingDate":1607058000000,"exchange":"NASDAQ","adjPreClose":9.79,"postHourTrading":{"tag":"盘后","latestPrice":9.8,"preClose":9.79,"latestTime":"17:01 EST","volume":20823,"amount":203811.95,"timestamp":1770674490515,"change":0.01,"changeRate":0.001021,"amplitude":0.02145},"volumeRatio":0.7740209895009263,"impliedVol":1.5746,"impliedVolPercentile":0.96},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPRY\",,,,,undefined,":{"symbol":"SPRY","floatShares":55270496,"roa":"-19.22%","roe":"-45.92%","lyrEps":0.079999,"volumeRatio":0.7740209895009263,"shares":98848611,"dividePrice":0,"high":10.07,"amplitude":0.047856,"preClose":10.03,"low":9.59,"week52Low":6.66,"pbRate":"6.55","psRate":"6.78","week52High":18.9,"institutionHeld":0,"latestPrice":9.79,"committee":-0.818182,"eps":-0.81541,"divideRate":0,"volume":933297,"delay":0,"ttmEps":-0.81541,"open":9.99,"prevYearClose":11.65,"prevWeekClose":10.03,"prevMonthClose":9.99,"prevQuarterClose":11.65,"fiveDayClose":10.3,"twentyDayClose":13.06,"sixtyDayClose":8.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"SPRY","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"SPRY","fiscalQuarterEnding":"2025/06","expectedEps":-0.41,"name":null,"time":"盘前","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-05-14","symbol":"SPRY","fiscalQuarterEnding":"2025/03","expectedEps":-0.35,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-03-20","symbol":"SPRY","fiscalQuarterEnding":"2024/12","expectedEps":-0.04,"name":null,"time":"盘前","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":0.52},{"market":"US","date":"2025-01-13","symbol":"SPRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPRY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1762491600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPRY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPRY","date":"2026-02-06","current":-12.00623,"percent":0.808974,"low":-115.157754,"twenty":-30.006457,"median":-18.060207,"eighty":-12.27233,"high":184.020638,"avg":-17.019046,"sd":47.915463,"marketCap":955866068},"quantilePoints":[{"date":"2022-11-11","current":-28.534516,"twenty":-28.349227,"median":-28.071294,"eighty":-27.904534,"marketCap":577624216},{"date":"2022-11-18","current":-27.515427,"twenty":-28.349227,"median":-28.00181,"eighty":-27.867476,"marketCap":556994780},{"date":"2022-11-25","current":-28.627161,"twenty":-29.164499,"median":-28.302905,"eighty":-27.978649,"marketCap":579499619},{"date":"2022-12-02","current":-32.332942,"twenty":-29.813011,"median":-28.534516,"eighty":-27.978649,"marketCap":654515751},{"date":"2022-12-09","current":-33.352032,"twenty":-32.629404,"median":-28.951417,"eighty":-27.987913,"marketCap":675145188},{"date":"2022-12-16","current":-37.428392,"twenty":-33.870842,"median":-29.970507,"eighty":-28.034236,"marketCap":757662933},{"date":"2022-12-23","current":-37.428392,"twenty":-36.761351,"median":-31.221208,"eighty":-28.136145,"marketCap":757662933},{"date":"2022-12-30","current":-39.512894,"twenty":-37.428392,"median":-32.842487,"eighty":-28.39555,"marketCap":799859507},{"date":"2023-01-06","current":-33.490999,"twenty":-37.558094,"median":-33.236227,"eighty":-28.506723,"marketCap":677958292},{"date":"2023-01-13","current":-34.510089,"twenty":-37.428392,"median":-33.352032,"eighty":-28.608632,"marketCap":698587729},{"date":"2023-01-20","current":-24.704541,"twenty":-37.261632,"median":-32.981454,"eighty":-28.089644,"marketCap":627322403},{"date":"2023-01-27","current":-23.338221,"twenty":-36.955904,"median":-32.518231,"eighty":-27.978649,"marketCap":592627442},{"date":"2023-02-03","current":-26.292426,"twenty":-36.631648,"median":-30.109473,"eighty":-26.233342,"marketCap":667643574},{"date":"2023-02-10","current":-28.323442,"twenty":-36.44636,"median":-29.576768,"eighty":-26.233342,"marketCap":719217165},{"date":"2023-02-17","current":-31.868488,"twenty":-36.103575,"median":-29.970507,"eighty":-27.026227,"marketCap":809236523},{"date":"2023-02-24","current":-30.539096,"twenty":-35.51065,"median":-30.109473,"eighty":-27.543213,"marketCap":775479264},{"date":"2023-03-03","current":-33.641011,"twenty":-34.760229,"median":-30.612951,"eighty":-27.668279,"marketCap":854246203},{"date":"2023-03-10","current":-29.025066,"twenty":-34.306271,"median":-30.649879,"eighty":-27.867476,"marketCap":737033496},{"date":"2023-03-17","current":-31.056082,"twenty":-33.963486,"median":-30.631415,"eighty":-27.978649,"marketCap":788607087},{"date":"2023-03-24","current":-20.659679,"twenty":-33.801144,"median":-30.612951,"eighty":-27.867476,"marketCap":716518982},{"date":"2023-03-31","current":-17.719962,"twenty":-33.618064,"median":-30.576023,"eighty":-26.2038,"marketCap":614563712},{"date":"2023-04-06","current":-15.732931,"twenty":-33.565575,"median":-30.176574,"eighty":-25.70897,"marketCap":545649501},{"date":"2023-04-14","current":-16.631178,"twenty":-33.492841,"median":-29.970507,"eighty":-24.113699,"marketCap":576802501},{"date":"2023-04-21","current":-17.973502,"twenty":-33.463206,"median":-29.344076,"eighty":-23.419462,"marketCap":623356984},{"date":"2023-04-28","current":-17.210989,"twenty":-33.352032,"median":-29.090384,"eighty":-19.070054,"marketCap":596911536},{"date":"2023-05-05","current":-16.693286,"twenty":-33.350744,"median":-28.918758,"eighty":-18.073817,"marketCap":578956528},{"date":"2023-05-12","current":-12.329028,"twenty":-33.323434,"median":-28.627161,"eighty":-17.841072,"marketCap":427595344},{"date":"2023-05-19","current":-17.294264,"twenty":-33.212652,"median":-28.359496,"eighty":-17.789501,"marketCap":733155735},{"date":"2023-05-26","current":-17.057707,"twenty":-33.123305,"median":-28.101877,"eighty":-17.789501,"marketCap":723127390},{"date":"2023-06-02","current":-15.358643,"twenty":-33.120421,"median":-28.024971,"eighty":-17.719962,"marketCap":651098973},{"date":"2023-06-09","current":-15.179795,"twenty":-32.981454,"median":-27.978649,"eighty":-17.665522,"marketCap":643517035},{"date":"2023-06-16","current":-13.525443,"twenty":-32.939388,"median":-27.584891,"eighty":-17.230009,"marketCap":573384103},{"date":"2023-06-23","current":-14.352619,"twenty":-32.898926,"median":-26.292426,"eighty":-16.984823,"marketCap":608450569},{"date":"2023-06-30","current":-14.777385,"twenty":-32.852687,"median":-26.033933,"eighty":-16.443167,"marketCap":626457673},{"date":"2023-07-07","current":-14.374975,"twenty":-32.778571,"median":-25.664657,"eighty":-16.200645,"marketCap":609398311},{"date":"2023-07-14","current":-15.381,"twenty":-32.650157,"median":-24.815323,"eighty":-15.896248,"marketCap":652046716},{"date":"2023-07-20","current":-16.342312,"twenty":-32.522678,"median":-23.947525,"eighty":-15.738555,"marketCap":692799635},{"date":"2023-07-28","current":-14.889165,"twenty":-32.268091,"median":-23.449004,"eighty":-15.666005,"marketCap":631196385},{"date":"2023-08-04","current":-15.649273,"twenty":-31.980646,"median":-22.434463,"eighty":-15.664922,"marketCap":663419624},{"date":"2023-08-11","current":-12.27233,"twenty":-31.772476,"median":-20.321699,"eighty":-15.577733,"marketCap":654642902},{"date":"2023-08-18","current":-12.05734,"twenty":-31.358888,"median":-18.902086,"eighty":-15.443597,"marketCap":643174706},{"date":"2023-08-25","current":-12.361909,"twenty":-31.218563,"median":-18.499284,"eighty":-15.287104,"marketCap":659421318},{"date":"2023-08-30","current":-12.70231,"twenty":-31.152094,"median":-18.359623,"eighty":-15.152968,"marketCap":677579296},{"date":"2023-09-08","current":-13.114373,"twenty":-31.100395,"median":-18.231502,"eighty":-15.005417,"marketCap":699560007},{"date":"2023-09-15","current":-13.04271,"twenty":-31.033926,"median":-18.031385,"eighty":-14.777385,"marketCap":695737274},{"date":"2023-09-20","current":-11.833393,"twenty":-31.022847,"median":-18.002563,"eighty":-14.750557,"marketCap":631228667},{"date":"2023-09-27","current":-6.718429,"twenty":-31.011769,"median":-17.988032,"eighty":-14.670075,"marketCap":358381151},{"date":"2023-10-05","current":-7.166324,"twenty":-30.867751,"median":-17.964938,"eighty":-14.419687,"marketCap":382273228},{"date":"2023-10-13","current":-6.718429,"twenty":-30.668342,"median":-17.875755,"eighty":-14.196126,"marketCap":358381151},{"date":"2023-10-20","current":-6.055544,"twenty":-30.649879,"median":-17.782874,"eighty":-14.047454,"marketCap":323020877},{"date":"2023-10-27","current":-6.306365,"twenty":-30.649879,"median":-17.728408,"eighty":-14.012806,"marketCap":336400440},{"date":"2023-11-03","current":-6.539271,"twenty":-30.635108,"median":-17.710569,"eighty":-13.713234,"marketCap":348824320},{"date":"2023-11-10","current":-5.319172,"twenty":-30.612951,"median":-17.665522,"eighty":-13.225451,"marketCap":327799293},{"date":"2023-11-17","current":-7.025405,"twenty":-30.612951,"median":-17.36121,"eighty":-12.859969,"marketCap":432947606},{"date":"2023-11-24","current":-7.41484,"twenty":-30.59818,"median":-17.220775,"eighty":-12.627063,"marketCap":456946919},{"date":"2023-12-01","current":-7.523882,"twenty":-30.480012,"median":-17.057707,"eighty":-12.494486,"marketCap":463666727},{"date":"2023-12-08","current":-8.1314,"twenty":-30.216835,"median":-16.553813,"eighty":-12.335604,"marketCap":501105655},{"date":"2023-12-15","current":-8.115823,"twenty":-30.090944,"median":-16.431736,"eighty":-12.243664,"marketCap":500145682},{"date":"2023-12-22","current":-7.944471,"twenty":-30.007565,"median":-16.309818,"eighty":-8.996418,"marketCap":489585985},{"date":"2023-12-29","current":-8.770073,"twenty":-29.979771,"median":-16.222884,"eighty":-8.287174,"marketCap":540464528},{"date":"2024-01-05","current":-8.785651,"twenty":-29.917293,"median":-16.174641,"eighty":-8.399331,"marketCap":541424501},{"date":"2024-01-12","current":-9.112776,"twenty":-29.704533,"median":-16.005127,"eighty":-8.58626,"marketCap":561583924},{"date":"2024-01-19","current":-9.471056,"twenty":-29.440705,"median":-15.977907,"eighty":-8.629876,"marketCap":583663292},{"date":"2024-01-26","current":-10.156461,"twenty":-29.180978,"median":-15.857321,"eighty":-8.707763,"marketCap":625902083},{"date":"2024-02-02","current":-9.969533,"twenty":-29.156298,"median":-15.732931,"eighty":-8.773189,"marketCap":614382412},{"date":"2024-02-09","current":-10.109729,"twenty":-29.07732,"median":-15.682807,"eighty":-8.798113,"marketCap":623022165},{"date":"2024-02-16","current":-11.309188,"twenty":-29.025066,"median":-15.649273,"eighty":-8.900923,"marketCap":696940049},{"date":"2024-02-23","current":-11.83882,"twenty":-29.025066,"median":-15.515136,"eighty":-9.112776,"marketCap":729579115},{"date":"2024-03-01","current":-13.038279,"twenty":-28.81245,"median":-15.453657,"eighty":-9.20624,"marketCap":803496999},{"date":"2024-03-08","current":-13.941768,"twenty":-28.8035,"median":-15.381,"eighty":-9.20624,"marketCap":859175405},{"date":"2024-03-15","current":-14.019655,"twenty":-28.627161,"median":-15.258041,"eighty":-9.237395,"marketCap":863975268},{"date":"2024-03-22","current":-15.975609,"twenty":-28.534516,"median":-15.179795,"eighty":-9.252972,"marketCap":868513986},{"date":"2024-03-28","current":-17.679674,"twenty":-28.423343,"median":-15.269219,"eighty":-9.315282,"marketCap":961155477},{"date":"2024-04-05","current":-16.916395,"twenty":-28.337864,"median":-15.369822,"eighty":-9.405631,"marketCap":919659809},{"date":"2024-04-12","current":-16.401625,"twenty":-28.264358,"median":-15.43689,"eighty":-9.46171,"marketCap":891674358},{"date":"2024-04-19","current":-14.981571,"twenty":-28.131419,"median":-15.49278,"eighty":-9.483518,"marketCap":814473115},{"date":"2024-04-26","current":-14.360297,"twenty":-28.077411,"median":-15.403356,"eighty":-9.636176,"marketCap":780697571},{"date":"2024-05-03","current":-16.860498,"twenty":-28.034236,"median":-15.420123,"eighty":-9.72341,"marketCap":916620967},{"date":"2024-05-10","current":-17.157732,"twenty":-27.987913,"median":-15.505955,"eighty":-9.779488,"marketCap":852670667},{"date":"2024-05-17","current":-17.742813,"twenty":-27.978649,"median":-15.537492,"eighty":-9.809086,"marketCap":881746829},{"date":"2024-05-24","current":-17.157885,"twenty":-27.978649,"median":-15.649273,"eighty":-9.876069,"marketCap":852678252},{"date":"2024-05-31","current":-17.313866,"twenty":-27.867476,"median":-15.716341,"eighty":-9.910338,"marketCap":860429873},{"date":"2024-06-07","current":-17.177383,"twenty":-27.668279,"median":-15.746992,"eighty":-9.932147,"marketCap":853647205},{"date":"2024-06-14","current":-16.884919,"twenty":-27.543213,"median":-15.872834,"eighty":-9.957071,"marketCap":839112916},{"date":"2024-06-21","current":-15.929536,"twenty":-27.026227,"median":-15.872834,"eighty":-9.981995,"marketCap":791634241},{"date":"2024-06-28","current":-16.592455,"twenty":-26.233342,"median":-15.857321,"eighty":-10.038073,"marketCap":824578628},{"date":"2024-07-05","current":-17.742813,"twenty":-26.122559,"median":-15.901185,"eighty":-10.097267,"marketCap":881746829},{"date":"2024-07-12","current":-22.129772,"twenty":-26.004391,"median":-15.977907,"eighty":-10.112844,"marketCap":1099761155},{"date":"2024-07-19","current":-20.550467,"twenty":-25.84191,"median":-16.008119,"eighty":-10.131537,"marketCap":1021275998},{"date":"2024-07-26","current":-21.408361,"twenty":-25.598187,"median":-16.06602,"eighty":-10.234348,"marketCap":1063909910},{"date":"2024-08-02","current":-19.302621,"twenty":-25.251068,"median":-16.155521,"eighty":-10.620668,"marketCap":959263034},{"date":"2024-08-09","current":-23.520911,"twenty":-24.881793,"median":-16.206368,"eighty":-10.941562,"marketCap":1054724705},{"date":"2024-08-16","current":-28.81744,"twenty":-25.84191,"median":-16.286222,"eighty":-11.035026,"marketCap":1292231647},{"date":"2024-08-23","current":-28.017556,"twenty":-27.270827,"median":-16.393243,"eighty":-11.081758,"marketCap":1256363252},{"date":"2024-08-30","current":-28.060793,"twenty":-27.941591,"median":-16.401625,"eighty":-11.197031,"marketCap":1258302084},{"date":"2024-09-06","current":-24.558599,"twenty":-27.79336,"median":-16.442915,"eighty":-11.309188,"marketCap":1101256678},{"date":"2024-09-13","current":-28.752585,"twenty":-27.79336,"median":-16.472628,"eighty":-11.620736,"marketCap":1289323399},{"date":"2024-09-20","current":-31.930502,"twenty":-27.995938,"median":-16.576918,"eighty":-11.620736,"marketCap":1431827564},{"date":"2024-09-27","current":-30.95767,"twenty":-28.060793,"median":-16.631178,"eighty":-11.714201,"marketCap":1388203840},{"date":"2024-10-04","current":-30.67663,"twenty":-28.212122,"median":-16.751589,"eighty":-11.833393,"marketCap":1375601431},{"date":"2024-10-11","current":-31.39004,"twenty":-28.39555,"median":-16.860498,"eighty":-11.83882,"marketCap":1407592162},{"date":"2024-10-18","current":-34.567957,"twenty":-28.752585,"median":-16.884919,"eighty":-11.967761,"marketCap":1550096327},{"date":"2024-10-25","current":-31.930502,"twenty":-28.968769,"median":-17.021402,"eighty":-12.05734,"marketCap":1431827564},{"date":"2024-11-01","current":-32.989808,"twenty":-29.172776,"median":-17.10772,"eighty":-12.236498,"marketCap":1479328953},{"date":"2024-11-08","current":-36.837898,"twenty":-29.53085,"median":-17.177383,"eighty":-12.27233,"marketCap":1651885017},{"date":"2024-11-15","current":-27.728261,"twenty":-29.574087,"median":-17.203935,"eighty":-12.290246,"marketCap":1361568504},{"date":"2024-11-22","current":-27.708469,"twenty":-29.53085,"median":-17.216378,"eighty":-12.329028,"marketCap":1360596650},{"date":"2024-11-29","current":-28.717849,"twenty":-29.510269,"median":-17.294264,"eighty":-12.329028,"marketCap":1410161242},{"date":"2024-12-06","current":-27.748052,"twenty":-29.318167,"median":-17.323614,"eighty":-12.355333,"marketCap":1362540359},{"date":"2024-12-13","current":-23.552198,"twenty":-29.200708,"median":-17.377363,"eighty":-12.390575,"marketCap":1156507152},{"date":"2024-12-20","current":-22.127191,"twenty":-29.174826,"median":-17.429503,"eighty":-12.426406,"marketCap":1086533610},{"date":"2024-12-27","current":-21.355313,"twenty":-29.123341,"median":-17.460097,"eighty":-12.465821,"marketCap":1048631275},{"date":"2025-01-03","current":-22.146983,"twenty":-29.064257,"median":-17.508842,"eighty":-12.501652,"marketCap":1087505465},{"date":"2025-01-10","current":-22.245942,"twenty":-29.025066,"median":-17.556082,"eighty":-12.530317,"marketCap":1092364739},{"date":"2025-01-17","current":-24.878247,"twenty":-29.013807,"median":-17.625827,"eighty":-12.566149,"marketCap":1221621420},{"date":"2025-01-24","current":-27.866803,"twenty":-28.968769,"median":-17.665522,"eighty":-12.594815,"marketCap":1368371488},{"date":"2025-01-31","current":-25.768876,"twenty":-28.968769,"median":-17.692748,"eighty":-12.61273,"marketCap":1265354884},{"date":"2025-02-07","current":-23.591782,"twenty":-28.81744,"median":-17.719962,"eighty":-12.684394,"marketCap":1158450862},{"date":"2025-02-14","current":-23.7897,"twenty":-28.81245,"median":-17.725862,"eighty":-12.70231,"marketCap":1168169409},{"date":"2025-02-21","current":-22.245942,"twenty":-28.80529,"median":-17.742813,"eighty":-12.730975,"marketCap":1092364739},{"date":"2025-02-28","current":-20.741768,"twenty":-28.766646,"median":-17.750677,"eighty":-12.878556,"marketCap":1018503778},{"date":"2025-03-07","current":-21.474063,"twenty":-28.753554,"median":-17.783612,"eighty":-12.988431,"marketCap":1054462403},{"date":"2025-03-14","current":-23.492823,"twenty":-28.724796,"median":-17.918291,"eighty":-13.032048,"marketCap":1153591588},{"date":"2025-03-21","current":151.633005,"twenty":-28.645299,"median":-17.929848,"eighty":-12.988431,"marketCap":1212760777},{"date":"2025-03-28","current":153.227851,"twenty":-28.604711,"median":-17.78435,"eighty":-12.670061,"marketCap":1225516351},{"date":"2025-04-04","current":157.030944,"twenty":-28.551598,"median":-17.756493,"eighty":-12.515985,"marketCap":1255933491},{"date":"2025-04-11","current":172.365997,"twenty":-28.537065,"median":-17.742813,"eighty":-12.355333,"marketCap":1378583246},{"date":"2025-04-17","current":182.548472,"twenty":-28.53527,"median":-17.728408,"eighty":-12.28308,"marketCap":1460022683},{"date":"2025-04-25","current":168.930945,"twenty":-28.478265,"median":-17.719962,"eighty":-11.916185,"marketCap":1351109701},{"date":"2025-05-02","current":177.55989,"twenty":-28.413636,"median":-17.701176,"eighty":-11.620736,"marketCap":1420124003},{"date":"2025-05-09","current":165.034919,"twenty":-28.363303,"median":-17.672598,"eighty":-11.047488,"marketCap":1319949281},{"date":"2025-05-16","current":-85.348526,"twenty":-28.478265,"median":-17.679674,"eighty":-10.985179,"marketCap":1335704429},{"date":"2025-05-23","current":-91.122103,"twenty":-28.610323,"median":-17.701176,"eighty":-11.047488,"marketCap":1426060905},{"date":"2025-05-30","current":-97.209461,"twenty":-28.755493,"median":-17.719962,"eighty":-11.103567,"marketCap":1521328059},{"date":"2025-06-06","current":-84.344425,"twenty":-28.908237,"median":-17.728408,"eighty":-11.22507,"marketCap":1319990259},{"date":"2025-06-13","current":-90.369027,"twenty":-29.139819,"median":-17.742813,"eighty":-11.433807,"marketCap":1414275278},{"date":"2025-06-20","current":-99.845224,"twenty":-29.414401,"median":-17.756493,"eighty":-11.620736,"marketCap":1562577755},{"date":"2025-06-27","current":-113.463334,"twenty":-29.625971,"median":-17.78435,"eighty":-11.639429,"marketCap":1775701182},{"date":"2025-07-03","current":-103.673356,"twenty":-29.970507,"median":-17.918291,"eighty":-11.714201,"marketCap":1622488027},{"date":"2025-07-11","current":-112.835772,"twenty":-30.109473,"median":-17.96922,"eighty":-11.833393,"marketCap":1765879826},{"date":"2025-07-18","current":-115.157754,"twenty":-30.373971,"median":-18.060207,"eighty":-11.83882,"marketCap":1802218844},{"date":"2025-07-25","current":-112.459234,"twenty":-30.612951,"median":-18.156476,"eighty":-11.967761,"marketCap":1759987013},{"date":"2025-08-01","current":-110.953084,"twenty":-30.649879,"median":-18.318793,"eighty":-12.05734,"marketCap":1736415758},{"date":"2025-08-08","current":-110.764815,"twenty":-30.849578,"median":-18.491503,"eighty":-12.236498,"marketCap":1733469351},{"date":"2025-08-15","current":-29.781475,"twenty":-31.056082,"median":-18.779127,"eighty":-12.27233,"marketCap":1430017096},{"date":"2025-09-05","current":-22.001657,"twenty":-31.011769,"median":-19.029654,"eighty":-12.286663,"marketCap":1056453542},{"date":"2025-09-12","current":-20.890254,"twenty":-30.966274,"median":-19.71207,"eighty":-12.321272,"marketCap":1003087320},{"date":"2025-09-19","current":-20.43746,"twenty":-30.871196,"median":-20.12152,"eighty":-12.329028,"marketCap":981345526},{"date":"2025-09-26","current":-19.63478,"twenty":-30.797693,"median":-20.134768,"eighty":-12.355333,"marketCap":942803254},{"date":"2025-10-03","current":-21.157814,"twenty":-30.698248,"median":-20.149319,"eighty":-12.390575,"marketCap":1015934744},{"date":"2025-10-10","current":-23.833413,"twenty":-30.67,"median":-20.178749,"eighty":-12.426406,"marketCap":1144408982},{"date":"2025-10-17","current":-20.807928,"twenty":-30.653572,"median":-20.2775,"eighty":-12.47657,"marketCap":999134267},{"date":"2025-10-24","current":-19.861177,"twenty":-30.649879,"median":-20.299599,"eighty":-12.515985,"marketCap":953674152},{"date":"2025-10-31","current":-17.74128,"twenty":-30.620337,"median":-20.187599,"eighty":-12.551817,"marketCap":851883024},{"date":"2025-11-07","current":-16.866565,"twenty":-30.612951,"median":-20.149319,"eighty":-12.587649,"marketCap":809881831},{"date":"2025-11-14","current":-10.386267,"twenty":-30.612951,"median":-20.12152,"eighty":-12.426406,"marketCap":831316818},{"date":"2025-11-21","current":-8.311484,"twenty":-30.553867,"median":-19.933213,"eighty":-12.321272,"marketCap":665251152},{"date":"2025-11-28","current":-11.781806,"twenty":-30.491905,"median":-19.75827,"eighty":-12.164835,"marketCap":943015748},{"date":"2025-12-05","current":-12.312852,"twenty":-30.408561,"median":-19.63478,"eighty":-11.836649,"marketCap":985520651},{"date":"2025-12-12","current":-13.856589,"twenty":-30.373971,"median":-19.314339,"eighty":-11.916185,"marketCap":1109081415},{"date":"2025-12-19","current":-12.127603,"twenty":-30.309116,"median":-19.029654,"eighty":-12.021508,"marketCap":970693360},{"date":"2025-12-26","current":-14.177687,"twenty":-30.256997,"median":-18.779127,"eighty":-12.085445,"marketCap":1134782054},{"date":"2026-01-02","current":-14.387635,"twenty":-30.230821,"median":-18.672648,"eighty":-12.149382,"marketCap":1151586318},{"date":"2026-01-09","current":-13.523142,"twenty":-30.165419,"median":-18.491503,"eighty":-12.241889,"marketCap":1082392290},{"date":"2026-01-16","current":-13.696041,"twenty":-30.101841,"median":-18.441052,"eighty":-12.263452,"marketCap":1096231095},{"date":"2026-01-23","current":-13.053846,"twenty":-30.071312,"median":-18.318793,"eighty":-12.263452,"marketCap":1044829818},{"date":"2026-01-30","current":-12.621599,"twenty":-30.016829,"median":-18.156476,"eighty":-12.27233,"marketCap":1010232804},{"date":"2026-02-06","current":-11.942355,"twenty":-30.006457,"median":-18.060207,"eighty":-12.27233,"marketCap":955866068}],"updateTime":1770682180359},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPRY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609219534","title":"Ars Pharmaceuticals, Inc.盘中异动 临近收盘快速跳水5.03%报9.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609219534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609219534?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 04:53","pubTimestamp":1770324815,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日04时53分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.03%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Bone Biologics Corp C/Wts 13/10/2026 、Liminatus Pharma, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Aim Immunotech Inc.、Transcode Therapeutics, Inc.、Propanc Biopharma, Inc.较为活跃，换手率分别为2057.86%、1263.43%、275.36%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Bone Biologics Corp C/Wts 13/10/2026 、Aim Immunotech Inc.，振幅分别为106.67%、70.70%、68.24%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206045335a4817dca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206045335a4817dca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1186197538","title":"Eurneffy® 1毫克（肾上腺素鼻喷雾剂）获欧盟推荐批准，用于体重≥15公斤至＜30公斤儿童1型过敏反应（包括过敏性休克）的紧急治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1186197538","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186197538?lang=zh_cn&edition=fundamental","pubTime":"2026-02-02 21:03","pubTimestamp":1770037400,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals Inc. 宣布，其产品Eurneffy® 1毫克（肾上腺素鼻喷雾剂）已获得欧盟人用药品委员会（CHMP）的积极意见，建议批准该药物用于体重在15公斤至30公斤以下（含15公斤，不含30公斤）的儿童患者，紧急治疗1型过敏反应，其中包括可能危及生命的过敏性休克。这一推荐标志着在儿童严重过敏应急治疗领域取得了一项重要进展，为小体重患儿提供了一种潜在的非注射给药选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2603683635","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603683635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603683635?lang=zh_cn&edition=fundamental","pubTime":"2026-01-12 22:45","pubTimestamp":1768229110,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时45分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.24%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Day One Biopharmaceuticals, Inc.、Forte Biosciences, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为538.92%、111.61%、48.15%，振幅较大的相关个股有Pyxis Oncology, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Geovax Labs, Inc.，振幅分别为26.42%、25.56%、24.64%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222451097a17707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222451097a17707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1128364104","title":"ARS Pharmaceuticals将获400万美元监管里程碑付款，并有望获得高达8000万美元销售里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1128364104","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128364104?lang=zh_cn&edition=fundamental","pubTime":"2025-12-29 21:04","pubTimestamp":1767013484,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals（纳斯达克代码：SPRY）近日宣布，公司将获得一笔400万美元的监管里程碑付款。此外，根据相关协议条款，该公司还有资格获得最高达8000万美元的销售里程碑款项。这一进展标志着公司在商业化进程中迈出重要一步，也为未来业绩增长提供了有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1199872730","title":"Neffy®（肾上腺素鼻喷雾剂）在华获批，成为首个且唯一可用于社区治疗的过敏反应（严重过敏）急救产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1199872730","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199872730?lang=zh_cn&edition=fundamental","pubTime":"2025-12-29 21:03","pubTimestamp":1767013385,"startTime":"0","endTime":"0","summary":"肾上腺素鼻喷雾剂Neffy®已正式获得中国监管部门的批准，该产品是首个且目前唯一获批用于社区场景、治疗过敏反应（严重过敏）的肾上腺素制剂。这一批准为患者提供了更为便捷和及时的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1133887171","title":"异动解读 | ARS制药季度业绩亮眼，股价盘前飙升7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133887171","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133887171?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 20:38","pubTimestamp":1762778319,"startTime":"0","endTime":"0","summary":"周一盘前，ARS制药（股票代码：SPRY）股价大幅上涨7.34%，引起投资者广泛关注。\n\n这波涨势似乎源于公司刚刚发布的2025年第三季度财务报告。ARS制药在盘前公布了其最新季度业绩以及旗下产品Neffy®的最新进展，这份报告显然给市场带来了积极信号。\n\n尽管具体财务数据尚未完全披露，但投资者对这份报告反应热烈，推动股价在开盘前显著上涨。分析人士认为，这可能意味着公司的业绩超出市场预期，特别是Neffy®产品线的表现可能相当出色。随着交易日的开始，我们预计会看到更多关于ARS制药财报的详细分析和市场反应。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"1112333909","title":"ARS Pharmaceuticals公布2025年第三季度财务结果及Neffy®的亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=1112333909","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112333909?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 19:02","pubTimestamp":1762772540,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals公布2025年第三季度财务结果及Neffy®的亮点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2581317590","title":"Ars Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581317590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581317590?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 03:43","pubTimestamp":1762371834,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日03时43分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.05%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Sonnet Biotherapeutics Holdings, Inc.、Enveric Biosciences, Inc.涨幅较大，Lunai Bioworks Inc.、Immuron Limited、Metavia Inc.较为活跃，换手率分别为628.82%、88.40%、79.44%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Ethzilla Corporation C/Wts 06/11/2025、Lunai Bioworks Inc.，振幅分别为84.66%、75.37%、74.26%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106034355a48b58d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106034355a48b58d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1108658851","title":"ARS Pharma推出GET Neffy®以改善重度过敏反应患者对Neffy（肾上腺素鼻喷雾剂）的获取","url":"https://stock-news.laohu8.com/highlight/detail?id=1108658851","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108658851?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 21:01","pubTimestamp":1762261310,"startTime":"0","endTime":"0","summary":"ARS Pharma推出GET Neffy®，旨在为重度过敏反应患者改善对Neffy（肾上腺素鼻喷雾剂）的获取。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2578350371","title":"Ars Pharmaceuticals, Inc.盘中异动 临近收盘快速下跌5.08%报9.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578350371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578350371?lang=zh_cn&edition=fundamental","pubTime":"2025-10-25 03:32","pubTimestamp":1761334366,"startTime":"0","endTime":"0","summary":"北京时间2025年10月25日03时32分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.08%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Inhibrx Biosciences, Inc.、Genenta Science Spa、Neuphoria Therapeutics Inc.涨幅较大，Neuphoria Therapeutics Inc.、Theriva Biologics, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为3473.15%、2881.41%、2487.19%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025033246a6cc8e82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025033246a6cc8e82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2574772432","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574772432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574772432?lang=zh_cn&edition=fundamental","pubTime":"2025-10-10 23:03","pubTimestamp":1760108595,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时03分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.01%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102303159726ba39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102303159726ba39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1104287172","title":"ARS PHARMACEUTICALS INC全球知识产权组合为Neffy提供至少到2039年的保护","url":"https://stock-news.laohu8.com/highlight/detail?id=1104287172","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104287172?lang=zh_cn&edition=fundamental","pubTime":"2025-10-08 20:04","pubTimestamp":1759925072,"startTime":"0","endTime":"0","summary":"ARS PHARMACEUTICALS INC宣布，其与Neffy相关的全球知识产权组合将提供至少延续到2039年的专利保护。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1170206591","title":"ARS Pharmaceuticals就Neffy®（肾上腺素鼻喷剂）相关专利获得欧洲专利局有利决定","url":"https://stock-news.laohu8.com/highlight/detail?id=1170206591","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170206591?lang=zh_cn&edition=fundamental","pubTime":"2025-10-08 20:04","pubTimestamp":1759925054,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals就其Neffy®（肾上腺素鼻喷剂）相关专利获得了欧洲专利局的有利决定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2572837839","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.45%报10.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572837839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572837839?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 21:33","pubTimestamp":1759239239,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日21时33分，Ars Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.45%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Scisparc Ltd.、Anaptysbio, Inc.、Nanobiotix涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为898.49%、248.26%、247.74%，振幅较大的相关个股有Scisparc Ltd.、Silexion Therapeutics Corp、Barinthus Biotherapeutics Plc，振幅分别为19.51%、14.16%、11.49%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213359971a6979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213359971a6979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1146721721","title":"ARS Pharmaceuticals获得高达2.5亿美元贷款额度，与Ra Capital Management和Omers Life Sciences合作加速Neffy®在美国的商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1146721721","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146721721?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 04:06","pubTimestamp":1759176388,"startTime":"0","endTime":"0","summary":"ARS Pharmaceuticals获得高达2.5亿美元贷款额度，与Ra Capital Management和Omers Life Sciences合作加速Neffy®在美国的商业化","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"1132385495","title":"Neffy®（肾上腺素鼻喷剂）在日本获批，成为首个且唯一的无针头过敏反应（过敏性休克）紧急治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1132385495","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132385495?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 20:01","pubTimestamp":1758283315,"startTime":"0","endTime":"0","summary":"Neffy®（肾上腺素鼻喷剂）在日本获批，成为首个且唯一的无针头过敏反应（过敏性休克）紧急治疗药物","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"2568452409","title":"Ars Pharmaceuticals, Inc.盘中异动 临近收盘急速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568452409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568452409?lang=zh_cn&edition=fundamental","pubTime":"2025-09-17 03:41","pubTimestamp":1758051693,"startTime":"0","endTime":"0","summary":"北京时间2025年09月17日03时41分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.02%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Kalaris Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、冠科美博涨幅较大，Aptevo Therapeutics Inc.、Adaptimmune Therapeutics Plc、Silo Pharma, Inc.较为活跃，换手率分别为3424.63%、174.64%、119.10%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为89.58%、76.00%、44.27%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917034135a4ca1843&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917034135a4ca1843&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRY"],"gpt_icon":0},{"id":"1162831286","title":"异动解读 | ARS制药业绩报告后股价盘中大跌5.46%，尽管收入超预期但亏损仍然严重","url":"https://stock-news.laohu8.com/highlight/detail?id=1162831286","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162831286?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 21:35","pubTimestamp":1755092142,"startTime":"0","endTime":"0","summary":"ARS制药今日盘中大跌5.46%，主要受到其最新季度财报的影响。尽管公司收入超出预期，但仍然面临严重亏损，引发了投资者对其财务状况的担忧。根据公司发布的财报显示，截至6月30日的季度中，ARS制药调整后每股亏损0.46美元，略好于分析师预期的0.47美元亏损。值得注意的是，尽管今日股价出现大幅下跌，ARS制药的股价今年迄今为止仍上涨了57.9%。这表明尽管短期内面临挑战，但市场对公司的长期发展前景仍持积极看法。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SPRY"],"gpt_icon":0},{"id":"2559271601","title":"BUZZ-ARS Pharma 第二季度收入超出预期，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2559271601","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559271601?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 19:48","pubTimestamp":1755085680,"startTime":"0","endTime":"0","summary":"** 预计奈飞将于 2026 年上半年在中国获得监管部门批准** 截至 6 月 30 日，ARS 制药公司拥有现金、现金等价物和短期投资 2.401 亿美元。** 截至上次收盘，股价累计上涨 57.9 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4S3U50RU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRY","BK4139"],"gpt_icon":0},{"id":"2558661690","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.00%报16.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558661690?lang=zh_cn&edition=fundamental","pubTime":"2025-08-11 23:24","pubTimestamp":1754925885,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时24分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.00%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5577.18%、493.01%、169.67%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232445a6dfe09f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232445a6dfe09f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRY","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}